Compound ID | 597
Class: Macrolide (15-membered macrolide, ketolide)
Spectrum of activity: | Gram-positive |
Description: | Synthetic compound, derived from 15-methylerythromycin A |
Institute where first reported: | Johnson & Johnson Pharmaceutical |
Year first mentioned: | 2002 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Reason Dropped: | Likely to be due to the failure of Ketek (Telithromycin)- (LS) |
External links: | |
Citations: |
|